Glaxo's Alli Favored For OTC Weight-Loss Use By FDA Joint Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees voted 11-3 in favor of making Xenical available over the counter.
You may also be interested in...
Xenical Should Be Pulled From Market Due To Possible Precancer Ties, Public Citizen Says
A petition from the advocacy group comes days after GSK receives an “approvable” letter for the obesity drug’s Rx-to-OTC switch.
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement